Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Ovarian Neoplasms × Trabectedin × Clear all

Phase

Phase 3 5 Phase 2 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Ovarian Neoplasms 1

Interventions

niraparib 4 apatinib 2 Sevoflurane 2 Saline Solution 2 Propofol 2 Carboplatin 2 Bevacizumab 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1 palbociclib 1 olaparib 1 liposomal doxorubicin 1 lenvatinib 1 gadofosveset trisodium 1 fosaprepitant 1 ferrous fumarate 1 Tranexamic Acid 1 Trabectedin 1 Sunitinib 1 Sodium Chloride 1 Pharmacokinetics 1 Pafolacianine 1 Paclitaxel 1 LY 353381 1 Injections 1 Indocyanine Green 1 Dexamethasone 1 Aprepitant 1 Anesthesia, Inhalation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03164980 2025-03-20

COMPASS

North Eastern German Society of Gynaecological Oncology

Phase 4 Terminated

89 enrolled 20 charts

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡